Stabilitech signs $4 million contract with Defense Threat Reduction Agency

Stabilitech Ltd, the protein stabilisation company, announced today that it has signed a contract with the United States Defense Threat Reduction Agency (DTRA), an agency within the United States Department of Defense. The contract is to fund a programme of work to stabilise two novel biodefense vaccines using Stabilitech's proprietary vaccine stabilisation technology. Over the contract period, funding could amount to a total of $4 million over three years